Glioblastoma (GBM) is the most common and malignant primary brain tumor in adults. The current treatment regimes for glioblastoma demonstrated a low efficiency and offer a poor prognosis. Advancements in conventional treatment strategies have only yielded modest improvements in overall survival. The heat shockproteins, heme oxygenase-1 (HO-1) and Hsp90, serve these pivotal roles in tumor cells and have been identified as effective targets for developing therapeutics. This topic review summarizes the current preclinical and clinical evidences and rationale to define the potential of HO-1 and Hsp90 in GBM progression and chemoresistance.
Castracani C.C., Di Rosa M., Rappa F., Bono T., Furneri P.M., Avola R., et al. (2017). Role of heme oxygenase-1 (HSP32) and HSP90 in glioblastoma [10.3269/1970-5492.2017.12.21].
Role of heme oxygenase-1 (HSP32) and HSP90 in glioblastoma
Rappa F.;
2017-01-01
Abstract
Glioblastoma (GBM) is the most common and malignant primary brain tumor in adults. The current treatment regimes for glioblastoma demonstrated a low efficiency and offer a poor prognosis. Advancements in conventional treatment strategies have only yielded modest improvements in overall survival. The heat shockproteins, heme oxygenase-1 (HO-1) and Hsp90, serve these pivotal roles in tumor cells and have been identified as effective targets for developing therapeutics. This topic review summarizes the current preclinical and clinical evidences and rationale to define the potential of HO-1 and Hsp90 in GBM progression and chemoresistance.File | Dimensione | Formato | |
---|---|---|---|
EMBJ_policy.JPG
Solo gestori archvio
Descrizione: Licenza CC come da sito dell'editore
Tipologia:
Contratto con l'editore (ATTENZIONE: NON TRASFERIRE A SITO DOCENTE)
Dimensione
133.84 kB
Formato
JPEG
|
133.84 kB | JPEG | Visualizza/Apri Richiedi una copia |
k2_attachments_Castruccio_21.pdf
accesso aperto
Descrizione: versione editoriale
Tipologia:
Versione Editoriale
Dimensione
255.31 kB
Formato
Adobe PDF
|
255.31 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.